Early Infectious Disease Outpatient Follow-up of Outpatient Parenteral Antimicrobial Therapy Patients Reduces 30-Day Readmission.
case_control · Level III
Where this comes from
- Record sourced from PubMed, PMID 30721936.
- Also identified by DOI 10.1093/cid/ciz073.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
We conducted a case-control study to examine the association between outpatient infectious disease (ID) follow-up and risk of 30-day readmission in 384 patients receiving outpatient parenteral antimicrobial therapy. ID outpatient follow-up within 2 weeks was associated with lower risk of all-cause 30-day readmission (adjusted odds ratio, 0.33; P = .0001).
Medical subject headings
- Aftercare
- Anti-Bacterial Agents
- Communicable Diseases
- Outpatients
- Patient Readmission